Efficacy of S-1 after Pemetrexed in patient with non-squamous non-small cell carcinoma: a retrospective multi-institutional analysis

Efficacy of S-1 after Pemetrexed in patient with non-squamous non-small cell carcinoma: a retrospective multi-institutional analysis - Efficacy of S-1 after Pemetrexed in patient with non-squamous non-small cell carcinoma: a retrospective multi-institutional analysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000033374

Enrollment

Registered

2018-07-12

Start date

2018-06-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non small-cell lung cancer patients receiving both PEM and S-1

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Non small-cell lung cancer patients recieving PEM and S-1 between April 1, 2012 to March 31, 2017

Exclusion criteria

Exclusion criteria: Nothing

Design outcomes

Primary

Measure	Time frame
Response Rate of S-1	—

Countries

Japan

Contacts

Public ContactShinnosuke Takemoto

National Hospital Organization, Nagasaki Medical Center Respiratoey of Medicine

shinnosuke-takemoto@umin.ac.jp0957-52-3121

Outcome results